title: Access to drugs: the case of Abbott in Thailand.
authors.forename: Paul
authors.initials: P
authors.lastname: Cawthorne
authors.forename: Nathan
authors.initials: N
authors.lastname: Ford
authors.forename: David
authors.initials: D
authors.lastname: Wilson
authors.forename: Kannikar
authors.initials: K
authors.lastname: Kijtiwatchakul
authors.forename: Virat
authors.initials: V
authors.lastname: Purahong
authors.forename: Nimit
authors.initials: N
authors.lastname: Tianudom
authors.forename: Supatra
authors.initials: S
authors.lastname: Nacapew
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence; D004338:Drug Combinations; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D017320:HIV Protease Inhibitors / Q000191:economics / Q000600:supply & distribution; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence*; D006801:Humans; D061466:Lopinavir; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011744:Pyrimidinones / Q000191:economics / Q000600:supply & distribution*; D019438:Ritonavir / Q000191:economics / Q000600:supply & distribution*; D013785:Thailand
chemical_list: D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir